Breast Cancer
Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium
The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data.
Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions
In the study, presented at SABCS, researchers developed an 812-gene signature that could identify which patients with ductal carcinoma in situ need aggressive treatment.
RxPONDER Update Yields No Clear Guidance on Chemo Decisions for Younger Breast Cancer Patients
Premium
A large, randomized trial exploring the benefit of adding chemo to endocrine therapy for premenopausal women with Oncotype DX scores of 0 to 25 will likely be needed.
Exai Bio Raises $67.5M in Series A Round for Liquid Biopsy Early Cancer Detection Platform
The blood-based platform uses AI and machine learning algorithms to analyze cell-free RNA profiles, with a focus on orphan noncoding RNA.
Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People
Tumors in younger individuals exhibited a dysregulated molecular aging phenotype and were associated with hallmarks of premature senescence.